{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Oral+Clindamycin&page=2", "query": { "intervention": "Oral Clindamycin", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Oral+Clindamycin&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-27T11:07:00.646Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04198129", "title": "The Evaluation of Postoperative Antibiotics in Non-Infected Mandible Fractures", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Jaw Fractures", "Infection" ], "interventions": [ { "name": "Antibiotic treatment (Unasyn or Cleocin)", "type": "DRUG" }, { "name": "Antibiotic treatment (Augmentin or Cleocin)", "type": "DRUG" }, { "name": "Control Group", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 13, "start_date": "2020-10-01", "completion_date": "2022-03-20", "has_results": false, "last_update_posted_date": "2025-06-26", "last_synced_at": "2026-09-27T11:07:00.646Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04198129" }, { "nct_id": "NCT03176134", "title": "A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Bacterial Skin and Skin Structure Infections" ], "interventions": [ { "name": "Tedizolid phosphate", "type": "DRUG" }, { "name": "Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "11 Years", "sex": "ALL", "summary": "1 Day to 11 Years" }, "enrollment_count": 100, "start_date": "2019-01-20", "completion_date": "2023-07-06", "has_results": true, "last_update_posted_date": "2025-07-31", "last_synced_at": "2026-09-27T11:07:00.646Z", "location_count": 8, "location_summary": "San Diego, California • Chicago, Illinois • Detroit, Michigan + 5 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Royal Oak", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03176134" }, { "nct_id": "NCT04573504", "title": "Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Vaginal Laceration During Delivery" ], "interventions": [ { "name": "Augmentin/Flagyl or Augmentin/Clindamycin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 274, "start_date": "2020-09-23", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2024-04-02", "last_synced_at": "2026-09-27T11:07:00.646Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04573504" }, { "nct_id": "NCT01400867", "title": "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Infections, Pediatrics" ], "interventions": [ { "name": "Ceftaroline fosamil", "type": "DRUG" }, { "name": "Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam", "type": "DRUG" }, { "name": "Cephalexin or Clindamycin or Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Months to 17 Years" }, "enrollment_count": 163, "start_date": "2011-12", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2015-01-13", "last_synced_at": "2026-09-27T11:07:00.646Z", "location_count": 28, "location_summary": "Phoenix, Arizona • Orange, California • San Diego, California + 23 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01400867" }, { "nct_id": "NCT02800785", "title": "The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Appendicitis" ], "interventions": [ { "name": "Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin", "type": "DRUG" }, { "name": "Appendectomy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1552, "start_date": "2016-05", "completion_date": "2021-09-01", "has_results": true, "last_update_posted_date": "2023-05-06", "last_synced_at": "2026-09-27T11:07:00.646Z", "location_count": 25, "location_summary": "Sylmar, California • Torrance, California • Aurora, Colorado + 14 more", "locations": [ { "city": "Sylmar", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT02800785" }, { "nct_id": "NCT04234971", "title": "Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cleft Lip and Palate" ], "interventions": [ { "name": "Intervention group (DBM/BMP)", "type": "DRUG" }, { "name": "Control group(autologous ICBG)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "6 Years to 15 Years" }, "enrollment_count": 40, "start_date": "2021-06-14", "completion_date": "2028-01-01", "has_results": false, "last_update_posted_date": "2026-02-19", "last_synced_at": "2026-09-27T11:07:00.646Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04234971" }, { "nct_id": "NCT06120140", "title": "Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "Amivantamab IV", "type": "DRUG" }, { "name": "Amivantamab SC", "type": "DRUG" }, { "name": "Lazertinib", "type": "DRUG" }, { "name": "Doxycycline", "type": "DRUG" }, { "name": "Minocycline", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" }, { "name": "Chlorhexidine", "type": "DRUG" }, { "name": "Noncomedogenic skin moisturizer", "type": "OTHER" }, { "name": "Ruxolitinib", "type": "OTHER" }, { "name": "Tacrolimus", "type": "OTHER" }, { "name": "Zinc gluconate", "type": "DRUG" }, { "name": "Propranolol", "type": "DRUG" }, { "name": "Timolol", "type": "DRUG" }, { "name": "Clobetasol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 305, "start_date": "2024-02-16", "completion_date": "2030-06-30", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-27T11:07:00.646Z", "location_count": 28, "location_summary": "Chandler, Arizona • Duarte, California • Fullerton, California + 25 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06120140" }, { "nct_id": "NCT00729937", "title": "Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus \"STOP MRSA\"", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Staphylococcal Infection" ], "interventions": [ { "name": "Cephalexin", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Trimethoprim-sulfamethoxazole", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 2265, "start_date": "2009-04", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2015-02-18", "last_synced_at": "2026-09-27T11:07:00.646Z", "location_count": 5, "location_summary": "Phoenix, Arizona • Sylmar, California • Baltimore, Maryland + 2 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Sylmar", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00729937" }, { "nct_id": "NCT03333408", "title": "Determining the Necessity for Postoperative Antibiotics After Salivary Stent Placement", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Salivary Duct" ], "interventions": [ { "name": "Postoperative Oral Antibiotics (Clindamycin or Augmentin)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Our Lady of the Lake Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2018-06-15", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2023-11-01", "last_synced_at": "2026-09-27T11:07:00.646Z", "location_count": 1, "location_summary": "Baton Rouge, Louisiana", "locations": [ { "city": "Baton Rouge", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03333408" }, { "nct_id": "NCT01063270", "title": "Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hidradenitis Suppurativa" ], "interventions": [ { "name": "Clindamycin & Rifampin", "type": "DRUG" }, { "name": "Clindamycin + Rifampin along with NdYag Laser treatment", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 18, "start_date": "2010-02", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2022-07-22", "last_synced_at": "2026-09-27T11:07:00.646Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01063270" } ] }